China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...

The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study ...

Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical ...

East Midlands-based biotechnology company N4 Pharma has formed a new senior leadership team featuring consultants in drug ...

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

A new era of medical science is taking shape in Massachusetts. Our biotech companies are at work on a gene therapy that can cure deafness, treatments that slow the effects of aging, and a ...

The Massachusetts-based Organogenesis is developing a biomanufacturing facility at 100 Technology Way in Smithfield, Rhode ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Layoffs, slower hiring and federal cuts threaten biotech’s workforce just when the industry seeks to expand into empty real ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said ...

The deal “fits like a glove” for BioMarin’s business, according to an analyst who also thinks there could be a “valuable” ...

The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their ...